The Rejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-arterial Supplementation ( JUVENTAS ) trial is a randomized , double-blind , placebo-controlled clinical trial in 160 patients with severe , nonrevascularizable limb ischemia .